药物开发 药物开发
Kazuo Shigematsu1, Naoyuki Komori1, Hisakazu Yamagishi2
1Nagitsuji Hospital, Kyoto, Kyoto, Japan.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
脂肪酸衍生介质干细胞 (ADSCs) 在给药后立即显著降低胆酶水平. 这表明快速的神经调节效应,可能解释了各种神经疾病患者握力改善的趋势.
科学领域:
- 再生医学是一种再生医学.
- 神经科学是一个神经科学.
- 干细胞疗法是一种干细胞疗法.
背景情况:
- 脂质衍生性介质干细胞 (ADSCs) 在再生医学中表现有前景,因为它们的多效.
- 在ADSC给药后立即改善症状是令人惊的,挑战了再生效应的传统时间表.
研究的目的:
- 调查ADSC给药对血清胆酶水平和握力的直接影响.
- 探索ADSCs潜在的快速神经调节作用.
主要方法:
- 一项前性观察性研究,涉及21名接受ADSC治疗的患者.
- 测量血清胆酶和紧握强度,在ADSC给药前后进行测量.
- 分析来自帕金森病,ALS,阿尔茨海默病,COPD和PSP患者的数据.
主要成果:
- 在ADSC给药后观察到血清胆酶水平的统计显著下降 (p < 0.001).
- 观察到改善握力的一种非显著的趋势 (p = 0.119).
- 这项研究包括了患有神经和肺部疾病的不同患者群体.
结论:
- 服用ADSC会立即显著降低血清胆酶的水平.
- 胆化酶的减少可能表明乙胆活性增强,可能有助于改善握力.
- ADSCs可能会产生超出其再生能力的快速神经调节效应,这需要进一步研究.
更多相关视频
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
3.3K
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
451
相关概念视频
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation
279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
